Shih Chia Lin
Directeur/Membre du Conseil chez SYNCORE BIOTECHNOLOGY CO.,LTD
Profil
Shih Chia Lin is currently the Chief Executive Officer of Foundation of Medical Professionals Alliance In Taiwan, Director of TSC Bioventure Capital Corp., Director of TaiMed Biologics, Inc., Director of SynCore Biotechnology Co., Ltd., Director of UBI Pharma Inc., Director of Peng Wan-Ru Foundation, and Director of Locus Cell Co., Ltd.
Ms. Lin previously worked as a Director at Bora Pharmaceuticals Co., Ltd.
Ms. Lin received an undergraduate degree from National Taiwan University and a graduate degree from National Yang Ming University.
Postes actifs de Shih Chia Lin
| Sociétés | Poste | Début |
|---|---|---|
| SYNCORE BIOTECHNOLOGY CO.,LTD | Directeur/Membre du Conseil | 16/07/2018 |
| LOCUS CELL CO., LTD. | Directeur/Membre du Conseil | 31/05/2021 |
| UBI PHARMA INC. | Directeur/Membre du Conseil | - |
| TAIMED BIOLOGICS INC. | Directeur/Membre du Conseil | - |
| Peng Wan-Ru Foundation | Directeur/Membre du Conseil | - |
| Foundation of Medical Professionals Alliance In Taiwan | Directeur Général | - |
TSC Bioventure Capital Corp.
 TSC Bioventure Capital Corp. Investment ManagersFinance TSC Bioventure Capital Corp's investment targets include biomedical industries in the U.S., Canada, Europe, Singapore, Japan and Taiwan covering domains such as genetic engineering, bioinformatics, bio chips, biomedical materials, medical equipments, test kits, biopharmaceuticals and drug development. It provides financing for early and later stage capital requirements. | Directeur/Membre du Conseil | - |
Anciens postes connus de Shih Chia Lin
| Sociétés | Poste | Fin |
|---|---|---|
| BORA PHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | - |
Formation de Shih Chia Lin
| National Yang Ming University | Graduate Degree |
| National Taiwan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BORA PHARMACEUTICALS CO., LTD. | Health Technology |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Health Technology |
| LOCUS CELL CO., LTD. | Health Technology |
| UBI PHARMA INC. | Health Technology |
| TAIMED BIOLOGICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Peng Wan-Ru Foundation | |
| Foundation of Medical Professionals Alliance In Taiwan | |
TSC Bioventure Capital Corp.
TSC Bioventure Capital Corp. Investment ManagersFinance TSC Bioventure Capital Corp's investment targets include biomedical industries in the U.S., Canada, Europe, Singapore, Japan and Taiwan covering domains such as genetic engineering, bioinformatics, bio chips, biomedical materials, medical equipments, test kits, biopharmaceuticals and drug development. It provides financing for early and later stage capital requirements. | Finance |
